Pyrimidine salvage pathway in Mycobacterium tuberculosis.

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Tuberculosis (TB) remains a leading cause of death worldwide, caused by Mycobacterium tuberculosis.
• Increasing drug resistance and HIV co-infection necessitate novel therapeutic strategies.
• Understanding mycobacterial metabolism is crucial for identifying new drug targets.

Purpose of the Study:

• To review the enzymes of the Mycobacterium tuberculosis pyrimidine salvage pathway as potential targets for new anti-TB agents.
• To highlight the unique enzymatic features for rational drug design.
• To explore the role of this pathway in mycobacterial survival and latency.

Main Methods:

• Literature review of mycobacterial metabolism, focusing on the pyrimidine salvage pathway.
• Analysis of functional and structural data of key enzymes.
• Evaluation of pathway enzymes as targets for selective drug development.

Main Results:

• The pyrimidine salvage pathway is essential for M. tuberculosis survival.
• Enzymes in this pathway exhibit significant differences from human counterparts, offering selectivity.
• These enzymes may play a critical role in the survival of M. tuberculosis during the latent state.

Conclusions:

• Enzymes of the M. tuberculosis pyrimidine salvage pathway are attractive targets for developing novel anti-TB drugs.
• Functional and structural insights into these enzymes can guide the search for effective antimycobacterial compounds.
• Targeting this pathway presents a rational drug design approach against TB.